One of the UK’s leading commercial stage pharmaceutical companies, Vernalis takes promising product candidates along a commercially-focused path to market. We derive pipeline candidates both from successful collaborations with a number of global pharmaceutical businesses and our own research activities.
The strategy is to:
- Build a profitable and cash generative business
- Develop and commercialise low development-risk late-stage products for unmet medical needs in the US
- Partner all of our NCE drug candidates
- Leverage our structure- and fragment-based drug discovery expertise via collaborations with leading pharmaceutical companies